Kogan M J, Verebey K, Mule S J
Res Commun Chem Pathol Pharmacol. 1977 Sep;18(1):29-34.
First pass metabolism, metabolic clearance, volume of distribution and steady state plasma levels were estimated in man following acute and chronic 100 mg oral doses of naltrexone. Essentially no statistical differences was observed in these values between the acute and chronic physiologic state. The values for the first pass effect were 79.6 +/- 4.6% and 78.0 +/- 3.0% for acute and chronic treatment respectively. From our pharmacokinetic data an apparent chronic release rate (ACRR) for a sustained release preparation of naltrexone was calculated as 11.8 microgram/kg/hr. In practice a release rate of one half the ACRR should be sufficient to provide continuous antagonism of 25 mg i.v. heroin. In conclusion our data clearly indicate that naltrexone is an effective and safe narcotic antagonist in man.
在给予人体100毫克口服剂量的纳曲酮进行急性和慢性给药后,评估了首过代谢、代谢清除率、分布容积和稳态血浆水平。在急性和慢性生理状态下,这些值基本未观察到统计学差异。急性和慢性治疗的首过效应值分别为79.6±4.6%和78.0±3.0%。根据我们的药代动力学数据,计算出纳曲酮缓释制剂的表观慢性释放率(ACRR)为11.8微克/千克/小时。在实际应用中,ACRR的一半释放率应足以对25毫克静脉注射海洛因提供持续拮抗作用。总之,我们的数据清楚地表明,纳曲酮在人体中是一种有效且安全的麻醉拮抗剂。